% alzhub.org library filter % Source: https://alzhub.org/research?author=Dage+JL&access=free % 6 entries, in the order the page lists them. Built from alzhub.org's own records. % 0 entries have no readable author in the source record and carry no author field. @article{pontecorvo2022-36251300, author = {Pontecorvo, M. J. and Lu, M. and Burnham, S. C. and Schade, A. E. and Dage, J. L. and Shcherbinin, S. and Collins, E. C. and Sims, JR. and others}, title = {{Association of Donanemab Treatment With Exploratory Plasma Biomarkers in Early Symptomatic Alzheimer Disease: A Secondary Analysis of the TRAILBLAZER-ALZ Randomized Clinical Trial}}, journal = {JAMA neurology}, year = {2022}, doi = {10.1001/jamaneurol.2022.3392}, pmid = {36251300}, url = {https://doi.org/10.1001/jamaneurol.2022.3392} } @article{janelidze2021-33165506, author = {Janelidze, S. and Berron, D. and Smith, R. and Strandberg, O. and Proctor, N. K. and Dage, J. L. and Stomrud, E. and Palmqvist, S. and others}, title = {{Associations of Plasma Phospho-Tau217 Levels With Tau Positron Emission Tomography in Early Alzheimer Disease}}, journal = {JAMA neurology}, year = {2021}, doi = {10.1001/jamaneurol.2020.4201}, pmid = {33165506}, url = {https://doi.org/10.1001/jamaneurol.2020.4201} } @article{palmqvist2021-34031605, author = {Palmqvist, S. and Tideman, P. and Cullen, N. and Zetterberg, H. and Blennow, K. and {Alzheimer’s Disease Neuroimaging Initiative} and Dage, J. L. and Stomrud, E. and others}, title = {{Prediction of future Alzheimer's disease dementia using plasma phospho-tau combined with other accessible measures}}, journal = {Nature medicine}, year = {2021}, doi = {10.1038/s41591-021-01348-z}, pmid = {34031605}, url = {https://doi.org/10.1038/s41591-021-01348-z} } @article{capuano2025-41151002, author = {Capuano, A. W. and Bennett, D. A. and Dage, J. L. and Russ, K. A. and Arfanakis, K. and Lamar, M. and Barnes, L. L. and Schneider, J. A.}, title = {{Assessing Cognitive Decline and Dementia Risk in Black and White Older Adults With Blood Biomarkers pTau217, GFAP, NfL, and Aβ Ratio}}, journal = {Neurology}, year = {2025}, doi = {10.1212/WNL.0000000000214317}, pmid = {41151002}, url = {https://doi.org/10.1212/WNL.0000000000214317} } @article{mielke2021-34309632, author = {Mielke, M. M. and Frank, R. D. and Dage, J. L. and Jeromin, A. and Ashton, N. J. and Blennow, K. and Karikari, T. K. and Vanmechelen, E. and others}, title = {{Comparison of Plasma Phosphorylated Tau Species With Amyloid and Tau Positron Emission Tomography, Neurodegeneration, Vascular Pathology, and Cognitive Outcomes}}, journal = {JAMA neurology}, year = {2021}, doi = {10.1001/jamaneurol.2021.2293}, pmid = {34309632}, url = {https://doi.org/10.1001/jamaneurol.2021.2293} } @article{groot2022-35568889, author = {Groot, C. and Cicognola, C. and Bali, D. and Triana-Baltzer, G. and Dage, J. L. and Pontecorvo, M. J. and Kolb, H. C. and Ossenkoppele, R. and others}, title = {{Diagnostic and prognostic performance to detect Alzheimer's disease and clinical progression of a novel assay for plasma p-tau217}}, journal = {Alzheimer's research \& therapy}, year = {2022}, doi = {10.1186/s13195-022-01005-8}, pmid = {35568889}, url = {https://doi.org/10.1186/s13195-022-01005-8} }